Uncategorized

NovaBay Pharmaceuticals to Hold First Quarter 2016 Conference Call on May 12

by Business Wire • 2016/05/05 • 0 Comments

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, announces that it will report first quarter 2016 financial results after market close on Thursday, May 12. Management will hold an investment community conference call that day to discuss financial results and provide a company update. DATE: Thursday, May 12 TIME:

Full Story →

← Aerie Pharmaceuticals Completes Enrollment of Mercury 1 Phase 3 Registration Trial of RoclatanTM (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%

Eleven Biotherapeutics Reports First Quarter 2016 Financial Results →

Post navigation